MCM
MDT icon

Mork Capital Management’s Medtronic MDT Stock Holding History

Mork Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,890
Closed -$897K – 120
2023
Q4 		$897K Hold
10,890
– – 0.55% 112
2023
Q3 		$853K Hold
10,890
– – 0.67% 72
2023
Q2 		$959K Hold
10,890
– – 0.74% 58
2023
Q1 		$878K Hold
10,890
– – 0.71% 65
2022
Q4 		$846K Buy
+10,890
New +$883K 0.65% 71

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mork Capital Management's MDT Position: Q1 2024 in Review

Mork Capital Management sold out of Medtronic (MDT) in Q1 2024, closing a stake of 10,890 shares — an estimated $897K sold.

Mork Capital Management first reported a position in MDT in Q4 2022 and held it in 5 quarters. The position peaked at $959K in Q2 2023. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Mork Capital Management reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Mork Capital Management sold 10,890 Medtronic shares in Q1 2024, an estimated $897K.
  • Mork Capital Management first reported a position in Medtronic in Q4 2022 and held it in 5 quarters.
  • Mork Capital Management's Medtronic position peaked at $959K in Q2 2023.
  • 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Mork Capital Management's 13F filing for Q1 2024, filed 14 May 2024.